Aboutlawsuits.com reports that German medical officials have determined that the health risks associated with GlaxoSmithKline's diabetes drug make the medication "useless" and "harmful," leading to a recommendation that the nation's insurers should stop paying for its use. The decision comes just a month before a U.S. Food & Drug Administration (FDA) advisory panel meeting is held on Avandia.

We handle Avandia cases and are still accepting new cases. If you or a family member took Avandia and you believe may have suffered a heart attack or death, please contact the head of the pharmaceutical practice area, Todd Hageman.